C

Curis
D

CRIS

1.79000
USD
0.06
(3.47%)
مغلق
حجم التداول
2,488
الربح لكل سهم
-5
العائد الربحي
-
P/E
-0
حجم السوق
18,727,428
أصول ذات صلة
A
ARRY
0.80000
(11.51%)
7.75000 USD
C
CLDX
-0.150
(-0.68%)
21.950 USD
C
COCP
-0.01000
(-0.67%)
1.49000 USD
E
EXEL
1.840
(4.15%)
46.150 USD
N
NERV
0.01000
(0.58%)
1.72000 USD
المزيد
الأخبار المقالات

العنوان: Curis

القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.